These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
479 related articles for article (PubMed ID: 28796845)
1. Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP. Yu J; Oh PC; Kim M; Moon J; Park YM; Lee K; Suh SY; Han SH; Byun K; Ahn T; Kang WC PLoS One; 2017; 12(8):e0182829. PubMed ID: 28796845 [TBL] [Abstract][Full Text] [Related]
2. Soluble ST2 for Prediction of Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Receiving Primary PCI. Liu X; Hu Y; Huang W; Zhang G; Cao S; Yan X; Li L; Zhang L; Zheng X Int Heart J; 2019 Jan; 60(1):19-26. PubMed ID: 30464124 [TBL] [Abstract][Full Text] [Related]
3. Association of Soluble Suppression of Tumorigenicity with No-Reflow Phenomenon and Long-Term Prognosis in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome after Percutaneous Coronary Intervention. Zhang Q; Hu M; Ma S J Atheroscler Thromb; 2021 Dec; 28(12):1289-1297. PubMed ID: 33551392 [TBL] [Abstract][Full Text] [Related]
4. Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial. Jarai R; Huber K; Bogaerts K; Droogne W; Ezekowitz J; Granger CB; Sinnaeve PR; Ross AM; Zeymer U; Armstrong PW; Van de Werf FJ; Am Heart J; 2010 Jan; 159(1):131-40. PubMed ID: 20102879 [TBL] [Abstract][Full Text] [Related]
5. Effect of early tirofiban administration on N-terminal pro-B-type natriuretic peptide level in patients treated with primary percutaneous coronary intervention. Fabris E; Ottervanger JP; Hermanides RS; Ten Berg JM; Sinagra G; Koopmans PC; Giannitsis E; Hamm C; van 't Hof AWJ Catheter Cardiovasc Interv; 2019 Apr; 93(5):E293-E297. PubMed ID: 30585388 [TBL] [Abstract][Full Text] [Related]
6. N-Terminal Fragment of Pro B-type Natriuretic Peptide as a Marker of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction. Goussot S; Mousson C; Guenancia C; Stamboul K; Brunel P; Brunet D; Touzery C; Cottin Y; Zeller M Am J Cardiol; 2015 Sep; 116(6):865-71. PubMed ID: 26183794 [TBL] [Abstract][Full Text] [Related]
7. Serum NT-proBNP on admission can predict ST-segment resolution in patients with acute myocardial infarction after primary percutaneous coronary intervention. Peng B; Xia H; Ni A; Wu G; Jiang X Herz; 2015 Sep; 40(6):898-905. PubMed ID: 25997425 [TBL] [Abstract][Full Text] [Related]
8. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation. Niccoli G; Conte M; Marchitti S; Montone RA; Fracassi F; Grippo R; Roberto M; Burzotta F; Trani C; Leone AM; Bianchi F; Di Castro S; Volpe M; Crea F; Rubattu S Cardiovasc Revasc Med; 2016; 17(3):162-8. PubMed ID: 26987266 [TBL] [Abstract][Full Text] [Related]
9. The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study. He WF; Jiang L; Chen YY; Liu YH; Chen PY; Duan CY; Zeng LH; Fan HL; Wei XB; Guo W; Chen W; Li J; Li WS; Guo ZQ; Liu ZK; Tan N; Chen JY; He PC BMC Cardiovasc Disord; 2021 Apr; 21(1):202. PubMed ID: 33882836 [TBL] [Abstract][Full Text] [Related]
10. The impact of NT-proBNP on admission for early risk stratification of patients undergoing primary percutaneous coronary intervention. Ayhan E; Isık T; Uyarel H; Ergelen M; Cicek G; Ozyurtlu F; Ghannadian B; Tanboga IH Kardiol Pol; 2013; 71(2):165-75. PubMed ID: 23575711 [TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention. Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ; Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115 [TBL] [Abstract][Full Text] [Related]
12. Association of galectin-3 and soluble ST2 with in-hospital and 1-year outcomes in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Tymińska A; Kapłon-Cieślicka A; Ozierański K; Budnik M; Wancerz A; Sypień P; Peller M; Maksym J; Balsam P; Opolski G; Filipiak KJ Pol Arch Intern Med; 2019 Nov; 129(11):770-780. PubMed ID: 31642446 [TBL] [Abstract][Full Text] [Related]
13. Early discharge after primary percutaneous coronary intervention: the added value of N-terminal pro-brain natriuretic peptide to the Zwolle Risk Score. Schellings DA; Adiyaman A; Giannitsis E; Hamm C; Suryapranata H; Ten Berg JM; Hoorntje JC; Van't Hof AW J Am Heart Assoc; 2014 Nov; 3(6):e001089. PubMed ID: 25389283 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of NT-proBNP, 3D LA volume and LV dyssynchrony in patients with acute STEMI undergoing primary percutaneous intervention. Siva Sankara C; Rajasekhar D; Vanajakshamma V; Praveen Kumar BS; Vamsidhar A Indian Heart J; 2015; 67(4):318-27. PubMed ID: 26304563 [TBL] [Abstract][Full Text] [Related]
15. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome. Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480 [TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of alkaline phosphatase measured at time of presentation in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Oh PC; Lee K; Kim TH; Moon J; Park HW; Jang HJ; Park SD; Kwon SW; Suh J; Kang WC PLoS One; 2017; 12(2):e0171914. PubMed ID: 28182682 [TBL] [Abstract][Full Text] [Related]
18. Insights into the change in brain natriuretic peptide after ST-elevation myocardial infarction (STEMI): why should it be better than baseline? Ezekowitz JA; Théroux P; Welsh R; Bata I; Webb J; Armstrong PW Can J Physiol Pharmacol; 2007 Jan; 85(1):173-8. PubMed ID: 17487257 [TBL] [Abstract][Full Text] [Related]
19. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400 [TBL] [Abstract][Full Text] [Related]
20. The relationship between early recanalization and serum NT-proBNP levels in patients with a first ST-segment elevation myocardial infarction treated with primary coronary angioplasty. Szadkowska I; Goch JH; Polak L; Stepień H; Chizyński K Acta Cardiol; 2007 Oct; 62(5):479-84. PubMed ID: 17982969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]